Biykem Bozkurt MD, PhD, FHFSA, FACC, FAHA, FACP
The Mary and Gordon Cain Chair and Professor of Medicine; Associate Provost of Faculty Affairs; Senior Associate Dean of Faculty Development; Director, Winters Center for Heart Failure Research; Associate Director, Cardiovascular Research Institute; Vice-Chair of Medicine, Baylor College of Medicine, Houston, TexasDr. Biykem Bozkurt is an advanced heart failure and cardiac transplantation cardiologist at Baylor College of Medicine (BCM), Houston TX, where she serves as the Associate Provost of Faculty Affairs and Senior Associate Dean of Faculty Development, Mary and Gordon Cain Chair and Professor of Medicine; Director of Winters Center of Heart Failure; Vice-Chair of Department of Medicine and the Medicine Chief at the Michael E. DeBakey VA Medicine.
Dr. Bozkurt has served as a Senior Associate Editor for Circulation; heart failure section editor for the Journal of American College of Cardiology, and she was recently named as the Editor-in-Chief of JACC: Heart Failure. She served as the President of the Heart Failure Society of America in 2019-2020, led the Universal Definition and Classification of Heart Failure published in 2021 and currently is the Vice-Chair of the 2022 AHA/ACC Heart Failure Guidelines Writing Committee.
Throughout her career, Dr. Bozkurt has been recognized for excellence in clinical care, education, and leadership. She was the recipient of the American College of Cardiology Proctor Harvey MD Young Teacher Award in 2005, American College of Cardiology Gifted Educator Award in 2016, Presidential awards in Education and Master Clinician awards at Baylor College of Medicine and was listed in Clarivate World’s Highly Cited Researchers (top 1% Web of Science) in 2019 and 2020.
Dr. Bozkurt actively participates in clinical and translational research; presents at national and international scientific sessions; teaches medical students, residents, fellows at bedside and in the classroom setting; mentors trainees and faculty.
Disclosures
In the last 24 months, BB has received consulting fees from Amgen, Bristol Myers Squibb, scPharmaceuticals, Baxter Healthcare Corporation , Sanofi-Aventis, Relypsa, and Vifor, and serves on the Clinical Event Committee for GUIDE HF Trial sponsored by Abbott Vascular and Data Safety Monitoring Committee of ANTHEM trial (Autonomic REGULATION Therapy to Enhance Myocardial Function and Reduce progression of Heart Failure with reduced ejection fraction) sponsored by Liva Nova.